DNAJC22 belongs to the DnaJ (Hsp40) family of co-chaperones, which regulate Hsp70 ATPase activity during protein folding, degradation, and translocation . The recombinant form enables researchers to bypass endogenous expression limitations, facilitating mechanistic studies of its roles in stress response and disease pathways .
Host Organisms: E. coli, HEK293, wheat germ, and mammalian cell-free systems .
Yield: High-purity (>90%) preparations achieved via affinity chromatography (e.g., Ni-NTA for His-tagged variants) .
Co-Chaperone Activity: Facilitates Hsp70-mediated protein folding by stabilizing client proteins .
Regulatory Pathways: Transcriptional regulation by HNF4A identified via cross-species analysis (mouse, human, zebrafish) . Knockdown of HNF4A reduces DNAJC22 expression, linking it to metabolic and hepatic functions .
Key partners identified via STRING-DB and experimental studies:
Cancer: Overexpression of DNAJC27 (a partner) activates oncogenic ERK signaling, suggesting DNAJC22’s indirect role in cell transformation .
Metabolic Disorders: Reduced DNAJC22 levels correlate with HNF4A-deficient renal carcinoma and diabetic adipose tissue inflammation .
Current gaps include structural resolution of DNAJC22-Hsp70 complexes and in vivo validation of its role in stress adaptation. Commercial accessibility of tagged variants (e.g., Avi-tagged for interactome studies) could accelerate these efforts .
DNAJC22 (DnaJ heat shock protein family (Hsp40) member C22) primarily functions as a co-chaperone protein . As a member of the highly conserved DnaJ/Hsp40 family, it likely plays a role in protein folding and protein quality control pathways. The protein contains characteristic DnaJ domains that allow interaction with Hsp70 chaperones to facilitate protein folding processes .
Current research indicates membrane activity, suggesting potential involvement in membrane protein quality control or trafficking mechanisms . While the precise molecular mechanisms remain under investigation, its structural characteristics strongly support its classification as a co-chaperone within cellular protein homeostasis networks.
Human DNAJC22 has a predicted molecular weight of approximately 38 kDa . Structurally, the protein contains several key domains:
Chaperone J-domain superfamily region - critical for co-chaperone functionality
DnaJ domain - the signature domain that defines the DnaJ/Hsp40 family
TM2 domain - transmembrane region consistent with its predicted membrane activity
The protein's C-terminal region (amino acids 200 to C-terminus) contains important epitopes for antibody recognition, as evidenced by immunogen design for commercial antibodies . The full human protein sequence provides the foundation for recombinant protein expression systems.
DNAJC22 shows significant evolutionary conservation, with orthologs identified in various model organisms. In zebrafish (Danio rerio), the orthologous gene dnajc22 encodes a 338-amino acid protein (UniProtKB:E7F2F5) that shares domain architecture with human DNAJC22 . This conservation extends to the characteristic DnaJ domain and membrane-associated regions.
The zebrafish gene is located on chromosome 23, while the human DNAJC22 gene is positioned on chromosome 12 . Despite chromosomal location differences, the functional domains remain conserved, suggesting evolutionary pressure to maintain structural features important for biological activity.
For successful production of recombinant human DNAJC22, researchers typically employ several expression systems:
Bacterial expression systems: E. coli-based systems can be used for producing the soluble domains of DNAJC22, though the transmembrane regions may present solubility challenges.
Mammalian expression systems: Human cell lines such as HEK293 or CHO cells provide proper folding and post-translational modifications for full-length DNAJC22.
Fragment-based approach: Expression of specific regions (e.g., amino acids 200 to C-terminus) has proven successful for generating immunogens for antibody production .
When using bacterial systems, fusion tags (His, GST, MBP) can enhance solubility and facilitate purification. For full-length protein with membrane domains, detergent solubilization or nanodisc reconstitution may be necessary to maintain native structure.
Based on antibody validation studies, several cell types have been confirmed to express detectable levels of DNAJC22:
U-2 OS cells: Human osteosarcoma cells show positive immunofluorescent staining for DNAJC22 when fixed with PFA and permeabilized with Triton X-100 .
RT4 cells: Human urinary bladder transitional cell carcinoma cells exhibit detectable DNAJC22 by Western blot analysis .
These cell lines provide reliable experimental systems for studying endogenous DNAJC22 expression, localization, and function. When selecting cellular models, researchers should consider that membrane proteins often show cell-type specific expression patterns.
Multiple validated approaches exist for DNAJC22 detection in research settings:
Western Blot (WB): Anti-DNAJC22 polyclonal antibodies (such as ab220239) have been validated for WB at 1/100 dilution using RT4 cell lysates, with expected band size of 38 kDa . Optimal sample preparation includes standard SDS-PAGE with transfer to PVDF or nitrocellulose membranes.
Immunocytochemistry/Immunofluorescence (ICC/IF): Validated protocols involve PFA fixation followed by Triton X-100 permeabilization, using anti-DNAJC22 antibodies at 4μg/ml concentration for detection in U-2 OS cells .
qRT-PCR: For transcript analysis, researchers should design primers spanning exon-exon junctions to avoid genomic DNA amplification. The zebrafish dnajc22 gene has multiple transcript variants (dnajc22-201: 1,480 nt; dnajc22-202: 1,014 nt; dnajc22-203: 972 nt) , suggesting human DNAJC22 may also express multiple splice variants requiring careful primer design.
When combining detection methods, correlating protein levels with transcript abundance provides more comprehensive insights into DNAJC22 regulation.
Several approaches can be employed to develop DNAJC22 loss-of-function models:
CRISPR-Cas9 genome editing:
Design sgRNAs targeting exonic regions to disrupt protein coding
Target conserved DnaJ domains for functional disruption
Validate knockout by sequencing, Western blot, and functional assays
RNA interference (RNAi):
siRNA or shRNA approaches targeting conserved regions
Multiple siRNAs should be tested to identify optimal knockdown efficiency
Validate knockdown at both mRNA and protein levels
Model organism approaches:
When generating knockout models, researchers should consider potential compensatory mechanisms by other DnaJ family members that may mask phenotypes.
As a predicted co-chaperone, DNAJC22 likely engages in multiple protein-protein interactions that are critical to its function . Appropriate methods include:
Co-immunoprecipitation (Co-IP):
Proximity labeling approaches:
BioID or APEX2 fusion proteins to identify neighboring proteins
Particularly valuable for membrane-associated proteins like DNAJC22
MS analysis of biotinylated proteins reveals interaction networks
Yeast two-hybrid membrane system variants:
Split-ubiquitin systems adapted for membrane proteins
MYTH (Membrane Yeast Two-Hybrid) system for transmembrane protein interactions
Controls for proper membrane insertion are essential
When analyzing interaction data, bioinformatic filtering for known chaperone networks and membrane-associated proteins can enhance specificity and relevance of findings.
The predicted membrane activity of DNAJC22 presents specific experimental challenges :
Protein Purification Strategies:
Detergent selection critical (mild non-ionic detergents like DDM or LMNG)
Nanodiscs or liposome reconstitution for functional studies
Fusion proteins with solubility enhancers may stabilize the protein
Localization Studies:
Co-localization with membrane markers using confocal microscopy
Membrane fractionation techniques to isolate specific compartments
Live-cell imaging with fluorescent tags placed to minimize membrane insertion disruption
Functional Assays:
In vitro membrane binding assays with purified components
Liposome co-sedimentation to assess membrane association
Surface plasmon resonance to measure interaction kinetics with membrane mimetics
Researchers should always validate membrane topology predictions experimentally, as computational predictions may not capture the precise membrane orientation of DNAJC22.
The DnaJ/Hsp40 family includes numerous members with specialized functions. Methodological approaches for comparative analysis include:
Phylogenetic Analysis:
Multiple sequence alignment of DnaJ domains across family members
Identification of DNAJC22-specific sequence motifs outside conserved domains
Evolutionary rate analysis to identify functionally constrained regions
Domain Swap Experiments:
Replace the J-domain of DNAJC22 with that of other family members
Test chimeric proteins for functional complementation
Identify domains conferring functional specificity
Comparative Expression Analysis:
Transcriptomic analysis of expression patterns across tissues
Co-expression network analysis to identify functional clusters
Single-cell RNA sequencing to define cell-type specific expression patterns
This comparative approach contextualizes DNAJC22 within the broader family, providing insights into shared mechanisms and unique functions.
Despite advances in characterizing DNAJC22, several important knowledge gaps persist:
Molecular Substrates:
Identity of specific protein substrates remains largely unknown
Systematic approaches needed to identify client proteins
Challenges in distinguishing direct from indirect interactions
Regulatory Mechanisms:
Transcriptional and post-translational regulation poorly characterized
Potential role of membrane lipid composition in modulating activity
Relationship to cellular stress response pathways requires clarification
Physiological Roles:
Limited understanding of tissue-specific functions
Potential involvement in development or disease processes
Connection to broader cellular proteostasis networks
Addressing these gaps requires integration of structural biology, systems biology, and model organism approaches.
Modern imaging approaches offer powerful tools for investigating membrane-associated proteins like DNAJC22:
Super-resolution Microscopy:
STORM or PALM imaging for nanoscale localization
Direct visualization of DNAJC22 clustering within membranes
Multi-color imaging to assess co-localization with potential partners
Live-cell Dynamics:
FRAP (Fluorescence Recovery After Photobleaching) to measure mobility
Single-particle tracking to determine diffusion dynamics
Optogenetic approaches to trigger relocalization or activation
Correlative Light and Electron Microscopy (CLEM):
Precise localization within membranous compartments
Ultrastructural context for functional studies
Immunogold labeling to confirm specific localization
These methodologies provide dynamic, spatially resolved information that complements biochemical and genetic approaches.
Based on current knowledge, the most productive research approaches will combine:
Structural characterization of DNAJC22, focusing on membrane topology and interaction interfaces
Proteomic identification of interaction partners under various cellular conditions
Functional genomics using CRISPR screening to place DNAJC22 in cellular pathways
Comparative biology leveraging zebrafish and other model organisms with confirmed orthologs
Systems biology approaches to integrate multiple data types into coherent models
Researchers should prioritize methodological rigor, particularly in confirming antibody specificity and validating model systems for studying membrane-associated proteins.
Robust DNAJC22 research requires careful attention to several critical controls:
Antibody validation:
Knockout/knockdown controls to confirm specificity
Multiple antibodies targeting different epitopes when possible
Secondary antibody-only controls for immunofluorescence
Expression constructs:
Validation of proper membrane insertion for tagged constructs
Use of multiple tag positions (N-terminal vs. C-terminal)
Functional complementation to verify activity of recombinant protein
Functional assays:
Positive controls using known DnaJ family members
Negative controls with J-domain mutants
Dose-response relationships to establish specificity